BUR2 Antibody

What is BUR2 and what cellular functions does it participate in?

BUR2 functions as part of the BUR1/BUR2 complex involved in transcription regulation. This complex plays a significant role in phosphorylating Serine 2 (Ser2) of the RNA Polymerase II C-terminal domain (CTD), particularly near gene promoters. Research has shown that BUR1/BUR2 recruitment is enhanced by the phosphorylation of Serine 5 (Ser5) on the CTD by another kinase called KIN28 . This phosphorylation cascade is essential for proper transcription elongation. Additionally, BUR1/BUR2 contributes to histone modifications, including H2B ubiquitination and H3-K4 methylation, thereby influencing chromatin structure during transcription .

What types of BUR2 antibodies are commercially available?

Researchers can access polyclonal BUR2 antibodies purified by antigen affinity, specifically targeting recombinant BUR2 protein. For example, one commercially available antibody targets the BUR2 protein from Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) . These antibodies are typically unconjugated IgG isotypes designed for applications such as ELISA and Western blotting . When selecting a BUR2 antibody, researchers should verify specificity for their target organism as cross-reactivity may vary between species.

How should I validate a new BUR2 antibody for my research?

Validation of BUR2 antibodies requires multiple approaches. Begin with Western blotting using positive controls such as recombinant BUR2 protein and compare against pre-immune serum as a negative control . Some antibody suppliers provide these controls with their products. For further validation, perform knockdown or knockout experiments where possible to confirm signal specificity. Additionally, immunoprecipitation followed by mass spectrometry can verify that the antibody is capturing the intended target. Since BUR2 is associated with promoter-proximal regions of genes, ChIP-seq data showing enrichment at 5' ends of genes can provide functional validation of antibody specificity .

What are the recommended applications for BUR2 antibodies?

BUR2 antibodies are primarily validated for ELISA and Western blotting applications . They can also be employed in chromatin immunoprecipitation (ChIP) experiments to study BUR2 occupancy along genes, as demonstrated in studies examining the distribution of BUR1/BUR2 across genes like ARG1 . Immunofluorescence microscopy can be used to visualize BUR2 localization, particularly in the nucleus where transcription occurs. For co-immunoprecipitation experiments, BUR2 antibodies can help investigate interactions with other transcription factors, including components of the Pol II machinery and the Paf1 complex.

How can I optimize ChIP protocols for studying BUR2 recruitment to gene promoters?

Optimizing ChIP protocols for BUR2 requires careful consideration of crosslinking conditions and sonication parameters. Research has shown that BUR2 is preferentially recruited to the 5' ends of genes, with enrichment observed at locations where Ser5-phosphorylated CTD is abundant . Use a two-step crosslinking approach with DSG (disuccinimidyl glutarate) followed by formaldehyde to better preserve protein-protein interactions in the transcription complex. Sonication should be optimized to generate fragments of 200-300bp for high-resolution mapping of BUR2 occupancy. Include Ser5P CTD antibodies as a positive control, as BUR2 recruitment correlates with Ser5 phosphorylation patterns . For quantification, normalize BUR2 ChIP signals to input DNA and to a non-transcribed region such as a chromosome V intergenic region, similar to the approach used in published BUR2 occupancy studies .

What experimental approaches can reveal the relationship between BUR2 and CTD phosphorylation?

To investigate the relationship between BUR2 and CTD phosphorylation, implement a multi-faceted approach. Begin with ChIP-seq experiments using antibodies against BUR2, Ser5P-CTD, and Ser2P-CTD to map their genome-wide distribution patterns. Research has shown that BUR1/BUR2 contributes significantly to Ser2 phosphorylation near promoters, while CTK1 (another kinase) is responsible for Ser2P at promoter-distal sites . Use genetic approaches with temperature-sensitive or chemically-inhibitable BUR2 mutants to examine causality in the phosphorylation cascade. The bur1-CΔ mutant, which lacks the C-terminal CTD-interaction domain, can help determine if direct interaction with Ser5P-CTD is necessary for BUR2 function . Additionally, sequential ChIP (re-ChIP) experiments can determine if BUR2 and phosphorylated CTD co-occupy the same DNA molecules simultaneously.

How can I distinguish between BUR1 and BUR2 functions in transcription elongation?

Distinguishing between BUR1 and BUR2 functions requires targeted experimental approaches. While they function as a complex, BUR1 contains the catalytic kinase domain while BUR2 serves a regulatory role. Use co-immunoprecipitation with BUR2 antibodies followed by kinase assays to determine if the complex isolated via BUR2 maintains catalytic activity. Generate separation-of-function mutants that disrupt specific interactions; for example, the bur1-CΔ mutation impairs the association of BUR1/BUR2 with elongating Pol II molecules near promoters without eliminating the complex formation . Conduct ChIP experiments comparing BUR1 and BUR2 occupancy along genes, as studies have shown they follow similar distribution patterns with particular enrichment at 5' regions . Finally, analyze histone modification patterns (particularly H3-K4Me3) in cells with specific BUR1 or BUR2 mutations to identify distinct roles in chromatin modification pathways.

What are the best methods to study BUR2 interactions with other transcription factors?

To study BUR2 interactions with transcription factors, employ proximity-based protein interaction assays. BioID or APEX2 proximity labeling with BUR2 as the bait protein can identify the interaction network in living cells. For direct protein-protein interactions, use microscale thermophoresis or surface plasmon resonance with purified components. Co-immunoprecipitation with BUR2 antibodies followed by mass spectrometry can identify native interaction partners. Research has shown that BUR2 recruitment is independent of the Paf1 complex and SPT4, suggesting separate recruitment pathways . Additionally, implement ChIP-seq experiments for BUR2 alongside factors like SPT5, CTK1, and KIN28 to identify regions of co-occupancy, which can indicate functional relationships. For temporal dynamics, use rapid degradation systems (such as auxin-inducible degrons) to deplete potential interacting partners and monitor changes in BUR2 recruitment patterns.

What are optimal Western blotting conditions for detecting BUR2?

For optimal Western blotting detection of BUR2, use a 10% SDS-PAGE gel and transfer to PVDF membrane at 100V for 1 hour in cold transfer buffer containing 20% methanol. Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature. Incubate with primary BUR2 antibody at 1:1000 dilution overnight at 4°C . After washing with TBST (3 × 10 minutes), incubate with HRP-conjugated secondary antibody at 1:5000 for 1 hour at room temperature. After washing, develop using enhanced chemiluminescence. Include positive controls such as recombinant BUR2 protein alongside experimental samples . For detecting endogenous BUR2, enrichment through immunoprecipitation prior to Western blotting may be necessary due to potentially low expression levels. If background is problematic, try alternative blocking agents such as BSA or commercial blocking reagents, and consider more stringent washing conditions.

How can I optimize immunoprecipitation protocols with BUR2 antibodies?

For efficient BUR2 immunoprecipitation, begin with cell lysis using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, and protease/phosphatase inhibitors. Pre-clear lysates with protein A/G beads for 1 hour at 4°C. Incubate pre-cleared lysates with BUR2 antibody (2-5 μg per mg of protein) overnight at 4°C . Add fresh protein A/G beads and incubate for 2-3 hours. Wash beads 4-5 times with lysis buffer containing reduced detergent (0.1% NP-40). For studying BUR2 in the context of chromatin interactions, include low concentrations of DNase I in the lysis buffer to reduce chromatin-mediated co-precipitation. When investigating BUR2's interaction with phosphorylated CTD, incorporate phosphatase inhibitors such as sodium fluoride (50 mM) and sodium orthovanadate (1 mM). Elute proteins using either SDS sample buffer for Western blotting analysis or a gentle elution buffer (0.1 M glycine, pH 2.5) for maintaining complex integrity for subsequent functional assays.

What controls should be included in BUR2 antibody experiments?

Include comprehensive controls in all BUR2 antibody experiments. For Western blotting and immunoprecipitation, use pre-immune serum as a negative control to assess non-specific binding . Include recombinant BUR2 protein as a positive control to confirm antibody recognition . For genetic validation, implement BUR2 knockdown/knockout samples where available. In ChIP experiments, include control regions such as chromosome V intergenic regions to normalize background binding . When studying BUR2 localization genome-wide, compare with the distribution of known interacting partners such as Ser5-phosphorylated CTD to confirm expected co-localization patterns . For functional studies, include the bur1-CΔ mutant, which lacks the CTD-interaction domain, as a control for recruitment specificity . Finally, to assess antibody lot-to-lot variation, maintain reference samples that can be tested alongside new experiments with fresh antibody lots.

How should I interpret BUR2 ChIP signal patterns across genes?

When interpreting BUR2 ChIP signals, expect enrichment primarily at the 5' ends of genes, corresponding to promoter-proximal regions . This pattern aligns with BUR2's role in early transcription elongation. The distribution should correlate with Ser5-phosphorylated CTD signals, as BUR2 recruitment is enhanced by KIN28-mediated Ser5 phosphorylation . If using the bur1-CΔ mutant (lacking CTD interaction domain), anticipate reduced BUR2 occupancy, particularly at the 5' end of genes, shifting peak occupancy toward the 3' end . Calculate occupancy relative to both input DNA and non-transcribed regions to control for background. For genome-wide studies, analyze BUR2 enrichment in relation to transcription start sites, gene lengths, and expression levels. Compare BUR2 occupancy with histone modifications like H3-K4Me3, which are influenced by BUR1/BUR2 activity. Finally, assess differences in BUR2 recruitment patterns between housekeeping and inducible genes to understand context-dependent functions.

What could cause inconsistent results when using BUR2 antibodies?

Inconsistent results with BUR2 antibodies may stem from several factors. Antibody degradation is a common issue; store antibodies according to manufacturer recommendations and avoid repeated freeze-thaw cycles. Epitope masking can occur if BUR2 forms complexes with other proteins, particularly BUR1, or if post-translational modifications alter antibody recognition sites. Cross-reactivity with similar proteins might generate false-positive signals, especially with polyclonal antibodies . Batch-to-batch variation in antibody production can lead to different specificity profiles; maintain reference samples to benchmark new antibody lots. Cell type or growth condition differences can affect BUR2 expression levels and localization patterns. Lysis conditions may need optimization, as insufficient extraction from chromatin can reduce detection of nuclear proteins like BUR2. For ChIP experiments, variations in crosslinking efficiency can significantly impact results. Finally, differences in normalization approaches, particularly for ChIP data, can create apparent inconsistencies when comparing results across studies.

How can I use BUR2 antibodies to study the mechanism of transcription-coupled histone modification?

To study transcription-coupled histone modifications using BUR2 antibodies, implement sequential ChIP (re-ChIP) experiments. First, immunoprecipitate with BUR2 antibodies, then perform a second immunoprecipitation with antibodies against specific histone modifications such as H3-K4Me3 or H2B-Ub . This approach reveals whether BUR2 and modified histones co-occupy the same DNA regions. Conduct ChIP-seq for BUR2 alongside histone modifications at different time points after transcription induction to establish temporal relationships. Research has shown that BUR1/BUR2 promotes H2B-Ub through phosphorylation of RAD6 and also affects H3-K4Me3 and H3-K36Me3 patterns . Use genetic approaches with BUR2 mutants to determine causality - for example, the bur1-CΔ mutation reduces BUR1/BUR2 recruitment and should correspondingly alter histone modification patterns if directly linked . Finally, combine these approaches with transcription inhibitors to distinguish direct effects of BUR2 on histone modifications from indirect effects mediated through altered transcription.

How can single B cell antibody technology improve BUR2 antibody development?

Single B cell antibody technology offers significant potential for developing more specific BUR2 antibodies. This approach involves isolating individual B cells, sequencing their antibody genes, and expressing recombinant monoclonal antibodies . For BUR2-specific antibodies, researchers can isolate B cells from immunized animals using fluorescence-activated cell sorting (FACS) with fluorochrome-labeled BUR2 protein . This selective approach yields antibodies with higher specificity than traditional polyclonal methods . The technology also enables screening of different epitopes to generate antibody panels targeting distinct regions of BUR2, which would be valuable for distinguishing BUR2's various functional states. Single B cell approaches can be combined with high-throughput screening methods like microengraving to identify B cells producing antibodies with desired specificity profiles before gene cloning . These monoclonal antibodies can then be expressed in mammalian systems like HEK293 or CHO cells for consistent production , reducing the batch-to-batch variation inherent in polyclonal antibodies.

What approaches can assess BUR2 antibody quality using therapeutic antibody profiling methods?

To assess BUR2 antibody quality using therapeutic antibody profiling methods, implement the Therapeutic Antibody Profiler (TAP) approach with ABodyBuilder2, a deep learning-based structure prediction method . This methodology evaluates biophysical characteristics that influence antibody stability and specificity. For BUR2 antibodies, calculate the Patches of Surface Hydrophobicity (PSH), Patches of Surface Positive Charge (PPC), and Patches of Surface Negative Charge (PNC) metrics to predict potential non-specific interactions . Generate multiple structural models and calculate ensemble-averaged TAP metrics to account for side chain conformational variability . Compare metrics of different BUR2 antibody candidates to established thresholds derived from clinical-stage therapeutic antibodies as benchmarks for developability . For critical applications, consider conducting molecular dynamics simulations of the antibody Fv domains to further evaluate stability and binding characteristics . This computational profiling can help select BUR2 antibodies less likely to exhibit non-specific binding or aggregation during experimental use, thereby improving experimental reproducibility.